Sen­ate Fi­nance chair goes af­ter Am­gen again on US tax­es, ask­ing for pay­ment specifics

Sen­ate Fi­nance Chair Ron Wyden is ask­ing Am­gen again for more in­for­ma­tion on its fi­nan­cials as he con­tin­ues to dig in­to the way phar­ma com­pa­nies use sub­sidiaries in low- or ze­ro-tax coun­tries to low­er their bills.

The De­mo­c­rat sen­a­tor from Ore­gon said to­day that he sent Am­gen a fi­nal re­quest for “vol­un­tary com­pli­ance” to pro­vide spe­cif­ic in­for­ma­tion on Am­gen’s fi­nan­cials. The let­ter, ad­dressed to Am­gen CEO Robert Brad­way, asked him to ex­plain how Am­gen paid a low­er tax rate than the stan­dard cor­po­rate tax rate in the US of 21%.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN